Andrographolide inhibits nuclear factor- B activation through JNK-Akt-p65 signaling cascade in tumor necrosis factor- α -Stimulated vascular smooth muscle cells

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Chen, Yu Ying ^a   Hsu, Ming Jen ^b   Hsieh, Cheng Ying ^a,b   Lee, Lin Wen ^c   Chen, Zhih Cherng ^a,b,d,e   Sheu, Joen Rong ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANDROGRAPHOLIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; DITERPENE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL METABOLISM; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; INTRACELLULAR SIGNALING; MALE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULITIS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION;

ANIMALS; CELLS, CULTURED; DITERPENES; GENE EXPRESSION REGULATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904607592     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/130381     Document Type: Article

References (37)

1. McKellar G. E., McCarey D. W., Sattar N., McInnes I. B., Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nature reviews. Cardiology 2009 6 6 410 417 10.1038/nrcardio.2009.57 2-s2.0-69249222895
2. Swirski F. K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., Figueiredo J., Kohler R. H., Chudnovskiy A., Waterman P., Aikawa E., Mempel T. R., Libby P., Weissleder R., Pittet M. J., Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009 325 5940 612 616 10.1126/science.1175202 2-s2.0-68149119072
3. Yang Z., Gagarin D., St. Laurent G., Hammell N., Toma I., Hu C., Iwasa A., McCaffrey T. A., Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 8 1213 1219 10.1161/ATVBAHA.109.189407 2-s2.0-68149163335
4. Cartwright N., Murch O., McMaster S. K., Paul-Clark M. J., Van Heel D. A., Ryffel B., Quesniaux V. F. J., Evans T. W., Thiemermann C., Mitchell J. A., Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo. The American Journal of Respiratory and Critical Care Medicine 2007 175 6 595 603 10.1164/rccm.200608-1103OC 2-s2.0-33947318655 (Pubitemid 46438944)
5. Hattori Y., Matsumura M., Kasai K., Vascular smooth muscle cell activation by C-reactive protein. Cardiovascular Research 2003 58 1 186 195 10.1016/S0008-6363(02)00855-6 2-s2.0-0037401072 (Pubitemid 36351637)
6. + channel inhibitor, attenuated TNF-alpha-induced nitric oxide release by human umbilical vein endothelial cells. Journal of Biomedical Research 2013 27 5 386 393
7. Rzucidlo E. M., Signaling pathways regulating vascular smooth muscle cell differentiation. Vascular 2009 17 1 S15 S20 10.2310/6670.2008.00089 2-s2.0-70349250221
8. 1 agonist, aggretin, promotes proliferation and migration of VSMC through NF- B translocation and PDGF production. British Journal of Pharmacology 2009 156 5 846 856 10.1111/j.1476-5381.2008.00095.x 2-s2.0-66949161978
9. Hennessy B. T., Smith D. L., Ram P. T., Lu Y., Mills G. B., Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews Drug Discovery 2005 4 12 988 1004 10.1038/nrd1902 2-s2.0-32044466838
10. Ozes O. N., Mayo L. D., Gustin J. A., Pfeffer S. R., Pfeffer L. M., Donner D. B., NF- B activation by tumour necrosis factor requires tie Akt serine- threonine kinase. Nature 1999 401 6748 82 85 10.1038/43466 2-s2.0-0033517189 (Pubitemid 29418447)
11. Coon J. T., Ernst E., Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Medica 2004 70 4 293 298 10.1055/s-2004-818938 2-s2.0-2342582660 (Pubitemid 38594598)
12. Poolsup N., Suthisisang C., Prathanturarug S., Asawamekin A., Chanchareon U., Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials. Journal of Clinical Pharmacy and Therapeutics 2004 29 1 37 45 10.1046/j.1365-2710.2003.00534.x 2-s2.0-1342310109 (Pubitemid 38253535)
13. Hsieh C. Y., Hsu M. J., Hsiao G., Wang Y. H., Huang C. W., Chen S. W., Jayakumar T., Chiu P. T., Chiu Y. H., Sheu J. R., Andrographolide enhances nuclear factor- B subunit p65 Ser536 dephosphorylation through activation of protein phosphatase 2A in vascular smooth muscle cells. The Journal of Biological Chemistry 2011 286 8 5942 5955 10.1074/jbc.M110.123968 2-s2.0-79953175974
14. Chen Y. Y., Hsu M. J., Sheu J. R., Lee L. W., Hsieh C. Y., Andrographolide, a novel NF- kappa B inhibitor, induces vascular smooth muscle cell apoptosis via a ceramide-p47phox-ROS signaling cascade. Evidence-Based Complementary Alternative Medicine 2013 2013 10 821813 10.1155/2013/821813
15. Lu W., Lee J., Chou D., Jayakumar T., Fong T., Hsiao G., Sheu J., A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP. Journal of Molecular Medicine 2011 89 12 1261 1273 10.1007/s00109-011-0800- 0 2-s2.0-84655169528
16. Lu W. J., Lin K. H., Hsu M. J., Chou D. S., Hsiao G., Sheu J. R., Suppression of NF- B signaling by andrographolide with a novel mechanism in human platelets: Regulatory roles of the p38 MAPK-hydroxyl radical-ERK2 cascade. Biochemical Pharmacology 2012 84 7 914 924 10.1016/j.bcp.2012.06.030 2-s2.0-84865518873
17. Patel S., Celermajer D. S., Bao S., Atherosclerosis-underlying inflammatory mechanisms and clinical implications. The International Journal of Biochemistry and Cell Biology 2008 40 4 576 580 10.1016/j.biocel.2007.11.017 2-s2.0-39649087139
18. Hsiao G., Shen M., Chang W., Cheng Y., Pan S., Kuo Y., Chen T., Sheu J., A novel antioxidant, octyl caffeate, suppression of LPS/IFN- γ -induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells. Biochemical Pharmacology 2003 65 8 1383 1392 10.1016/S0006-2952(03)00070- 4 2-s2.0-0037446224 (Pubitemid 36407789)
19. Sprague A. H., Khalil R. A., Inflammatory cytokines in vascular dysfunction and vascular disease. Biochemical Pharmacology 2009 78 6 539 552 10.1016/j.bcp.2009.04.029 2-s2.0-67651146363
20. Dugourd C., Gervais M., Corvol P., Monnot C., Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation. Hypertension 2003 41 4 882 890 10.1161/01.HYP.0000060821.62417.35 2-s2.0-0037386779 (Pubitemid 36418461)
21. Hattori Y., Kasai K., Gross S. S., NO suppresses while peroxynitrite sustains NF- B: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO. Cardiovascular Research 2004 63 1 31 40 10.1016/j.cardiores. 2004.03.014 2-s2.0-2942574528 (Pubitemid 38759807)
22. Ghosh S., Karin M., Missing pieces in the NF- B puzzle. Cell 2002 109 2 S81 S96 10.1016/S0092-8674(02)00703-1 2-s2.0-0036234459 (Pubitemid 34457854)
23. Li Q., Verma I. M., NF- B regulation in the immune system. Nature Reviews Immunology 2002 2 10 725 734 10.1038/nri910 2-s2.0-0036781052 (Pubitemid 37328713)
24. Sasaki C. Y., Barberi T. J., Ghosh P., Longo D. L., Phosphorylation of Re1A/p65 on serine 536 defines an I B α-independent NF- B pathway. The Journal of Biological Chemistry 2005 280 41 34538 34547 10.1074/jbc.M504943200 2-s2.0-27144459692 (Pubitemid 41504584)
25. Chao C., Lii C., Tsai I.-T., Li C., Liu K., Tsai C., Chen H., Andrographolide inhibits ICAM-1 expression and NF- B activation in TNF- α -treated EA.hy926 cells. Journal of Agricultural and Food Chemistry 2011 59 10 5263 5271 10.1021/jf104003y 2-s2.0-79957935298
26. Chen H., Lin A., Chu H., Li C., Tsai C., Chao C., Wang C., Lii C., Liu K., Inhibition of TNF- α -induced inflammation by andrographolide via down-regulation of the PI3K/Akt signaling pathway. Journal of Natural Products 2011 74 11 2408 2413 10.1021/np200631v 2-s2.0-82355190327
27. Rectenwald J. E., Moldawer L. L., Huber T. S., Seeger J. M., Ozaki C. K., Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 2000 102 14 1697 1702 10.1161/01.CIR.102.14.1697 2-s2.0-0034601753
28. Gordon J. W., Shaw J. A., Kirshenbaum L. A., Multiple facets of NF- B in the heart: to be or not to NF- B. Circulation Research 2011 108 9 1122 1132 10.1161/CIRCRESAHA.110.226928 2-s2.0-79955605472
29. Guo D., Donner D. B., Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. The Journal of Biological Chemistry 1996 271 2 615 618 10.1074/jbc.271.2.615 2-s2.0-0030060604 (Pubitemid 26034903)
30. Kim S., Iwao H., Stress and vascular responses: mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling. Journal of Pharmacological Sciences 2003 91 3 177 181 10.1254/jphs.91.177 2-s2.0-0038702291 (Pubitemid 36575573)
31. Perkins N. D., Integrating cell-signalling pathways with NF- B and IKK function. Nature Reviews Molecular Cell Biology 2007 8 1 49 62 10.1038/nrm2083 2-s2.0-33845768987 (Pubitemid 46012014)
32. Shiojima I., Walsh K., Role of Akt signaling in vascular homeostasis and angiogenesis. Circulation Research 2002 90 12 1243 1250 10.1161/01.RES. 0000022200.71892.9F 2-s2.0-0037188941 (Pubitemid 34787405)
33. Fernández-Hernando C., Ackah E., Yu J., Suárez Y., Murata T., Iwakiri Y., Prendergast J., Miao R. Q., Birnbaum M. J., Sessa W. C., Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metabolism 2007 6 6 446 457 10.1016/j.cmet.2007.10.007 2-s2.0-36448943901 (Pubitemid 350163050)
34. Garcia J., Lemercier B., Roman-Roman S., Rawadi G., A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF- B activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways. The Journal of Biological Chemistry 1998 273 51 34391 34398 10.1074/jbc.273.51.34391 2-s2.0-0032545291 (Pubitemid 29008917)
35. Bergmann M., Hart L., Lindsay M., Barnes P. J., Newton R., I B α degradation and nuclear factor- B DNA binding are insufficient for interleukin-1 β and tumor necrosis factor- α -induced b-dependent transcription. Requirement for an additional activation pathway. The Journal of Biological Chemistry 1998 273 12 6607 6610 10.1074/jbc.273.12.6607 2-s2.0-0032549174 (Pubitemid 28160316)
36. Chiou W. F., Chen C. C., Wei B. L., 3,4-Di- O -caffeoylquinic acid inhibits angiotensin-II-induced vascular smooth muscle cell proliferation and migration by downregulating the JNK and PI3k/AKT signaling pathways. Evidence-Based Complementary and Alternative Medicine 2011 2011 8 634502 10.1093/ecam/nep140 2-s2.0-80052736710
37. Golden H. B., Watson L. E., Nizamutdinov D., Feng H., Gerilechaogetu F., Lal H., Verma S. K., Mukhopadhyay S., Foster D. M., Dillmann W. H., Dostal D. E., Anthrax lethal toxin induces acute diastolic dysfunction in rats through disruption of the phospholamban signaling network. International Journal of Cardiology 2013 168 4 3884 3895 10.1016/j.ijcard.2013.06.050 2-s2.0-84880617904